BioSpace News Archive

A documentary about Theranos will be shown at Sundance, while ABC News will unveil its own documentary on the company this week.

Now that Bristol-Myers Squibb is acquiring Celgene, the company will largely disappear into Bristol-Myers Squibb, but a legacy of bold risk-taking and questionable price hikes remain.

One area that pharma companies are now focusing on is bringing more tech into the industry. This is proving to be a smart idea as new technologies are already helping to revolutionize research.

A 2013 study that analyzes IPO withdrawals between 1999 and 2004 found that about 13 percent returned later for a successful IPO, 36 percent turned again to raising capital privately, and 42 percent either merged or were acquired by other companies—another common strategy for biotechs. And about 11 percent filed bankruptcy.

Shares of Cambridge, Mass.-based Editas Medicine are down nearly 20 percent after Chief Executive Officer Katrine Bosley abruptly announced her decision to resign from her role at the company effective March 1.

Heidelberg Pharma AG announced today that it has received a milestone payment from its cooperation partner Link Health Co., Guangzhou, China.

Biom’up has announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for its HEMOBLAST Bellows Laparoscopic Applicator for all minimally-invasive procedures. Biom’up submitted the premarket approval (PMA) supplement to the FDA in July, 2018.

Highest Ranked Japanese Company

INTEGRA has responded to customers’ requests and developed two new 24-channel pipetting heads, extending the capabilities of its popular VIAFLO 96/384.

CloudLIMS is pleased to host a complimentary webinar titled “Data Privacy and Other Clinical Data Management Challenges” on February 5, 2019.